Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-05-15 00:00:00 ET · period of report 2025-05-13 · accession 0001415889-25-013170 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-15 | 2025-05-13 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $1.59 | +2,872 | 99.5K | +3% | +$4,566 |
| D | 2025-05-15 | 2025-05-13 | KNSA | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $27.03 | -2,872 | 96.7K | -3% | -$77.6K |
| D | 2025-05-15 | 2025-05-13 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $0.00 | -2,872 | 88.6K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-05-13 | M | A | 2,872 | $1.59 | 99,546 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-05-13 | S | D | 2,872 | $27.03 | 96,674 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.00 and $27.06. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Derivative | Share Option | 2025-05-13 | M | D | 2,872 | $0.00 | 88,619 | D | $1.59 · — to 2025-12-15 | 2,872 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |